GeoVax Labs, Inc. GOVX, a clinical-stage biotech company, is trading higher on Wednesday as investors assess the company's ...

Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

GeoVax Labs, Inc. GOVX stock is pulling back in premarket trading on Tuesday after surging 79.67% to close sharply higher on ...

WHO Emergency Declaration of Ebola Outbreak and Ongoing Mpox Developments Reinforce the Importance of Diversified Vaccine ...

ATLANTA, GA, Aug. 20, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies, today ...

GeoVax (NASDAQ: GOVX) made significant progress with its pipeline in 2022; however, perhaps the most important milestone came in May 2022, when the company strengthened its balance sheet by raising ...

ATLANTA, GA, April 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious ...

ATLANTA, Feb. 9, 2011 /PRNewswire/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening ...

Public attention to HIV and AIDS has lessened in recent years, but that hasn’t slowed a small Smyrna medical biotechnology firm’s pursuit of vaccines to prevent and treat the virus. “Everybody thinks ...

ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today ...